Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Luma Meds vs PeptidesRx

Luma Meds
Graded #391

Lower grade

vs+6.299999999999997
PeptidesRx
Graded #247

Higher grade

The verdict

PeptidesRx takes it — 64.1/100 to 57.8/100.

PeptidesRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. PeptidesRx is a Fort Worth, TX-based licensed telehealth platform offering physician-supervised compounded semaglutide, tirzepatide, and a broader prescription peptide menu.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuePeptidesRx +29
32
61
Dose & formulationLuma Meds +10
64
54
Clinical oversightLuma Meds +5
90
85
Labs & monitoringEven
55
55
FulfillmentLuma Meds +6
76
70
Contract termsPeptidesRx +35
20
55
Luma Meds · left barPeptidesRx · right bar

The numbers

MetricLuma MedsPeptidesRx
WeighScore57.8/10064.1/100
GradeCC
Scorecard rank#391#247
Semaglutide$249/mo (compounded)$169/mo (0.25 mg dose, compounded)
Tirzepatide$299/mo (compounded)$309/mo (2.5 mg dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Luma Meds

Graded #391 · C

Strengths

  • LegitScript certified — a credibility mark fewer compounded GLP-1 providers carry
  • Free discreet shipping and unlimited 24/7 support on every plan
  • Compounded semaglutide and tirzepatide from FDA-regulated 503A/503B pharmacies
  • '100,000+ members treated' claim with physician-supervised online care
  • 3-month bundle pricing brings semaglutide as low as $140/mo

Where it loses points

  • Compounding pharmacy partner not publicly named
  • States available not published
  • Monthly semaglutide ($249/mo) is above many lower-cost compounded competitors
  • No oral formulation options listed
  • Compounded medications are not FDA-approved
PeptidesRx

Graded #247 · C

Strengths

  • Compliance-focused positioning vs gray-market vendors
  • Board-certified medical director
  • Transparent pricing with no surprise fees
  • Real prescriptions, not research-chemical channel

Where it loses points

  • Smaller scale than Henry Meds or Hims
  • Wide peptide menu may distract from GLP-1 focus

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard